‘There is a definite need to support SME upgradation’
Harish Jain, Secretary and Sunil Attavar, President, Karnataka Drugs & Pharmaceuticals Manufacturer’s Association
There is no…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘We expect the new govt to reduce regulatory intervention’
BR Sikri, Chairman, Fope
First let me highlight the good things done by the present government.:
Recently agreed to publish SQ…
A report card and a wishlist
Demonetisation, Swachh Bharat Abhiyan, Make in India, Digital India, Ayushmaan Bharat and implementation of GST have been the…
Lifesciences industry posts 53 deals worth $5.8 bn in April 2019
Novartis’ acquisition of IFM Therapeutics contribute 27 per cent to the total deal value
In April 2019, the healthcare industry…
‘Clinical research services at most leading pharma and biotech companies contain at least one…
Karan Daftary, Director, Business Development and Akshay Daftary, Director, Business Development, Siro Clinpharm, speak on the…
Post USTR Special 301 Report, pragmatism wins over confrontation?
While both governments continue the dialogue, there are various groups working to find a middle path
‘Interactive anti-bribery training is an essential element in building a culture of compliance’
The pharmaceutical sector has seen some high profile investigations and settlements concerning bribes given to healthcare…
Glenmark Pharmaceuticals receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules
The drug is a generic version of Nexium Delayed-Release Capsules, 20 mg and 40 mg, of AstraZeneca Pharmaceuticals LP
Regulations for pharma ingredients in India – Too much hope from a complex market in 2019
Active Pharmaceutical Ingredient production in India, though a rapidly expanding industry, still faces a lot of competition form…
UK MHRA’s approval for Wockhardt’s manufacturing facilities continue
The approval was sanctioned for the company's Bhimpore, Kadaiya plants in Daman